Revolution Medicines (RVMD) Asset Utilization Ratio (2020 - 2024)

Revolution Medicines' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.0 for Q3 2024.

• In Q3 2024, Asset Utilization Ratio fell 98.37% year-over-year to 0.0; the TTM figure through Sep 2024 stood at 0.0 (down 98.37% YoY), while the FY2023 annual figure was 0.01, down 82.35% from the prior year.
• Asset Utilization Ratio was 0.0 for Q3 2024 at Revolution Medicines, up from 0.0 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.14 in Q1 2020 to a low of 0.0 in Q2 2024.
• Historically, Asset Utilization Ratio has averaged 0.05 across 5 years, with a median of 0.04 in 2021.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio gained 8.26% in 2022, then plunged 98.55% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.07 in 2020, then tumbled by 46.04% to 0.04 in 2021, then climbed by 8.26% to 0.04 in 2022, then slumped by 82.4% to 0.01 in 2023, then plunged by 94.54% to 0.0 in 2024.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q3 2024), 0.0 (Q2 2024), and 0.0 (Q1 2024), per Business Quant data.